Greater Manchester can support materials-science companies through research, prototyping and early industrial development, but the region should not be judged by discoveries or programme announcements. A company has scaled only when it can make a repeatable product, meet a customer's specification, finance working capital and equipment, and win repeat orders at an economic margin. Those tests expose gaps that a strong research base alone cannot solve.

The decision for a founder is not simply whether Manchester has a materials cluster. It is whether the region provides the next required capability at the right time. The answer may be yes for research and pilot work, but conditional for production. Capital, specialist premises, quality systems, customer validation and management experience must arrive in sequence.

Define scale before counting companies

Materials businesses develop differently from software companies. A validated sample is not the same as a stable production process. A pilot line is not the same as capacity that can fulfil contracted volume. A funding round is not proof of customer demand. The relevant milestones are technical reproducibility, qualification by a buyer, repeat orders, manufacturing yield, contribution margin and the ability to finance growth.

Greater Manchester's advanced materials and manufacturing sector plan sets out a regional policy direction. It describes intended interventions across innovation, sites, skills and business support. It should be read as a plan, not a record of company outcomes.

For editorial and investment analysis, a company should be placed into one of five stages: discovery, prototype, application testing, qualified supply and scaled production. Each stage requires different evidence. This avoids placing a university project, a venture-backed developer and an established manufacturer in one undifferentiated company count.

The funding route should also follow the stage. The guide to R&D tax relief, grants and innovation loans explains why research support and production capital solve different problems. A grant that funds experimentation cannot be assumed to finance a factory or customer inventory.

Research strength matters only when companies can use it

Greater Manchester has universities and research organisations with materials and manufacturing capabilities. For a business, the useful question is whether a facility accepts external commercial work, on what terms, with what queue, intellectual-property position and technical support.

The UKRI Gateway to Research allows a founder or investor to trace publicly funded projects and participating organisations. The Innovate UK competition service shows current and previous funding calls. These records can identify activity, but neither establishes that a company has secured access or achieved a commercial result.

Before choosing a base, management should obtain written answers on equipment access, consumables, safety responsibilities, confidentiality, background intellectual property and publication rights. It should also identify the route from laboratory equipment to a production-representative process. A material that performs under research conditions may need different machinery, tolerances or quality controls at volume.

The best regional advantage is not proximity in the abstract. It is the ability to move quickly between a technical problem, a specialist facility and a customer who can validate the solution.

The first industrial customer is part of the production system

Advanced materials are usually sold into another company's product or process. The buyer may require testing, certification, supply assurance and evidence that a small supplier can survive a long qualification cycle. This makes customer access as important as laboratory access.

A founder should map likely applications and name the organisations that can approve use. The commercial team must know whether the decision sits with research, engineering, procurement, quality, operations or a regulated assurance function. Public contracts can be searched through Find a Tender, while private procurement may require supplier programmes and direct industry relationships.

Greater Manchester's broad industrial base may create routes into local validation, but a buyer's presence in the region does not prove willingness to work with start-ups. The company needs a documented test plan, success criteria, ownership of test data and a route from trial material to paid supply. A pilot without a commercial decision date can consume scarce production capacity without reducing market risk.

The parallel Sheffield investigation, what happens after advanced manufacturing research leaves the lab, uses the same test: commercialisation is visible in protected know-how, repeat customers and durable production, not participation alone.

Specialist premises and equipment create the middle-stage gap

Materials companies can outgrow a university laboratory before they can support a conventional industrial lease. They may need extraction, unusual power, gas, water, waste handling, floor loading or planning consent. A generic office or light-industrial unit may be unusable without expensive work.

The Greater Manchester Investment Zone is intended to support advanced materials and manufacturing through sites, innovation, skills and finance. Its published programme helps a company identify relevant locations and support. It does not remove the need to verify that a specific unit is complete, connected, affordable and permitted for the proposed process.

Management should price fit-out, equipment, commissioning, maintenance, insurance and downtime. It should also model yield and working capital at conservative volumes. Moving too early into owned production can fix the wrong process in expensive equipment. Moving too late can leave the company unable to fulfil a qualified order.

Contract manufacturing, shared pilot facilities and equipment leasing can bridge part of this gap. Their effect on intellectual property, quality control and delivery risk must be explicit.

Capital must match long technical and sales cycles

Materials companies often need money before qualification revenue arrives. They may also require capital expenditure, inventory and customer-specific development. Standard venture milestones can fit poorly when technical validation and procurement take years.

The GM Advance investment fund is one regional source designed for advanced manufacturing and materials businesses. Eligibility, product terms and availability must be confirmed at the time of application. National grant, debt and equity routes may also apply.

London remains relevant because many growth investors, advisers and corporate finance teams are concentrated there. It should be treated as a source of relationships and capital, not as the required location of the operating company. The later article on raising growth capital without moving to London will test that distinction across a wider company sample.

A credible financing plan connects each tranche to a de-risking event: reproducible process, independent validation, customer qualification, first paid order or proven production yield. It also includes downside cash needs if qualification or commissioning takes longer than planned.

Some functions can move without moving the company

Research, application engineering and pilot production benefit from being close when technical feedback is frequent. Manufacturing leadership should be close to the process. Customer teams may need to sit near target industries rather than the laboratory. Investor relations and specialist advisory work can be handled through regular London access without transferring the whole business.

This functional design is more useful than arguing about headquarters. Companies House provides a legal registered office, not a reliable map of employment or operational work. Any study of regional retention should use actual sites, employee evidence and production activity rather than registration alone. Companies House company information remains valuable for accounts, charges and filing history when its limits are understood.

The board should review location after customer qualification, a significant equipment purchase or a major funding round. Those are the points at which production, management and capital needs can change sharply.

Public programmes should be audited by delivery stage

Announcements can describe funding envelopes, target jobs and expected private investment. Those are useful statements of intent. They are not realised outcomes. A transparent audit should classify support as approved, contracted, under construction, operational or completed, then connect it to company use.

The same discipline applies to companies. A press release about a pilot does not establish a paid order. A facility launch does not show utilisation. A funding round does not show scale. Greater Manchester will have demonstrated a strong commercialisation system when more firms move through qualification into repeat manufacturing while retaining meaningful operating work in the region.

Limitations

Detailed production volume, yield, customer qualification and facility-utilisation data are usually private. Public company filings can lag current operations and may combine activity across locations. Regional strategies use boundaries and sector definitions that are not always consistent with national statistics.

This draft does not yet include the required company and customer reporting. Before publication, it should test at least one company that reached repeat production, one that moved a function elsewhere and one delayed or unsuccessful case. Public investment targets must be updated and kept separate from delivered facilities, contracts and employment.

Reporting by Shoreditch Talk